CME Group price target raised to $225 from $222 at Barclays

Barclays raised the firm’s price target on CME Group to $225 from $222 and keeps an Equal Weight rating on the shares. The company reported a Q4 earnings beat, driven by top- and bottom-line outperformance and helped a bit by lower taxes in the quarter, the analyst tells investors in a research note. The firm says the tone of the earnings call was “quite bullish” as CME sees ongoing market uncertainty and geopolitical risks, among other factors, that are generally positive for its business.